CYP1A2 and breast carcinoma: Although the mechanism behind the finding of the present study is not fully understood, the current study provides new insight into how the CYP1A2 rs762551 combined with the functional AhR Arg554Lys variant is linked to prognosis in AI-treated breast cancer patients.